Ghost Tree Capital, LLC

Holdings History for BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX)

Symbol: BCRX on Nasdaq
Investment type: Equity / Common Stock

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2023		-0.51%	$0	0	-200,000	-100%	$6.55	Q3 2023
30 Jun 2023	0.51%	-0.19%	$1,408,000	200,000	-75,000	-27%	$7.04	Q2 2023
31 Mar 2023	0.87%	+0.16%	$2,294,000	275,000	+50,000	+22%	$8.34	Q1 2023
31 Dec 2022	1.1%	-1.5%	$2,583,000	225,000	-300,000	-57%	$11.48	Q4 2022
30 Sep 2022	2.7%	+1%	$6,615,000	525,000	+200,000	+62%	$12.60	Q3 2022
30 Jun 2022	2.4%	-0.18%	$3,439,000	325,000	-25,000	-7.1%	$10.58	Q2 2022
31 Mar 2022	2.8%	+2.8%	$5,691,000	350,000	+350,000	NEW	$16.26	Q1 2022
30 Jun 2021		-1.4%	$0	0	-500,000	-100%	$6.55	Q2 2021
31 Mar 2021	1.4%	-1.1%	$5,085,000	500,000	-400,000	-44%	$10.17	Q1 2021
31 Dec 2020	1.7%	-1.9%	$6,705,000	900,000	-1,050,000	-54%	$7.45	Q4 2020
30 Sep 2020	2.3%	+0.06%	$6,698,000	1,950,000	+50,000	+2.6%	$3.43	Q3 2020
30 Jun 2020	3%	-0.16%	$9,054,000	1,900,000	-100,000	-5%	$4.77	Q2 2020
31 Mar 2020	1.8%	-0.88%	$4,000,000	2,000,000	-1,000,000	-33%	$2.00	Q1 2020
31 Dec 2019	2.8%	+1.4%	$10,350,000	3,000,000	+1,500,000	+100%	$3.45	Q4 2019
30 Sep 2019	1.5%	-1%	$4,298,000	1,500,000	-1,000,000	-40%	$2.87	Q3 2019
30 Jun 2019	2.5%	+2%	$9,475,000	2,500,000	+2,000,000	+400%	$3.79	Q2 2019
31 Mar 2019	1.2%	0%	$4,070,000	500,000	0		$8.14	Q1 2019
31 Dec 2018	2%	0%	$4,035,000	500,000	0		$8.07	Q4 2018
30 Sep 2018	0.98%	+0.98%	$3,815,000	500,000	+500,000	NEW	$7.63	Q3 2018
31 Dec 2017		-0.78%	$0	0	-500,000	-100%	$6.55	Q4 2017
30 Sep 2017	0.78%	-0.27%	$2,620,000	500,000	-175,000	-26%	$5.24	Q3 2017
30 Jun 2017	1.1%	-1.3%	$3,753,000	675,000	-825,000	-55%	$5.56	Q2 2017
31 Mar 2017	3.4%	+0.79%	$12,600,000	1,500,000	+350,000	+30%	$8.40	Q1 2017
31 Dec 2016	2.2%	-1.2%	$7,280,000	1,150,000	-650,000	-36%	$6.33	Q4 2016
30 Sep 2016	2.3%	+0.13%	$7,938,000	1,800,000	+100,000	+5.9%	$4.41	Q3 2016
30 Jun 2016	2.3%	+2.3%	$4,828,000	1,700,000	+1,700,000	NEW	$2.84	Q2 2016
31 Dec 2015		-1.3%	$0	0	-225,000	-100%	$6.55	Q4 2015
30 Sep 2015	1.3%	+1%	$2,565,000	225,000	+180,000	+400%	$11.40	Q3 2015
30 Jun 2015	0.22%	+0.22%	$672,000	45,000	+45,000	NEW	$14.93	Q2 2015

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.